Cargando…

Antibody development for preventing the human respiratory syncytial virus pathology

Human respiratory syncytial virus (hRSV) is the most important etiological agent causing hospitalizations associated with respiratory diseases in children under 5 years of age as well as the elderly, newborns and premature children are the most affected populations. This viral infection can be assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soto, Jorge A., Gálvez, Nicolás M. S., Pacheco, Gaspar A., Bueno, Susan M., Kalergis, Alexis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164255/ https://www.ncbi.nlm.nih.gov/pubmed/32303184 http://dx.doi.org/10.1186/s10020-020-00162-6

Ejemplares similares

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
por: Diethelm-Varela, Benjamín, et al.
Publicado: (2023)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2022)

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)

The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses
por: Soto, Jorge A., et al.
Publicado: (2020)

Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice
por: Soto, Jorge A., et al.
Publicado: (2021)

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2017)

Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
por: Bohmwald, Karen, et al.
Publicado: (2019)

Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
por: Rey-Jurado, Emma, et al.
Publicado: (2017)

Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus
por: Acevedo, Orlando A., et al.
Publicado: (2019)

Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus
por: Bohmwald, Karen, et al.
Publicado: (2017)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
por: Abarca, Katia, et al.
Publicado: (2020)

Neurologic Alterations Due to Respiratory Virus Infections
por: Bohmwald, Karen, et al.
Publicado: (2018)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
por: Soto, Jorge A., et al.
Publicado: (2018)

Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2017)

The prevention of respiratory syncytial virus infection
por: Bollani, L, et al.
Publicado: (2014)

Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System
por: Soto, Jorge A., et al.
Publicado: (2018)

Host Components That Modulate the Disease Caused by hMPV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2021)

Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells
por: Tognarelli, Eduardo I., et al.
Publicado: (2019)

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection
por: Lanari, Marcello, et al.
Publicado: (2013)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Peña, Marcela, et al.
Publicado: (2020)

Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection
por: Bawage, Swapnil S., et al.
Publicado: (2019)

Respiratory syncytial virus: diagnosis, prevention and management
por: Barr, Rachael, et al.
Publicado: (2019)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
por: Vázquez, Yaneisi, et al.
Publicado: (2019)

Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Tiwari, Pooja Munnilal, et al.
Publicado: (2018)

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
por: Resch, Bernhard
Publicado: (2017)

Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
por: Díaz, Fabián E., et al.
Publicado: (2021)

Contribution of hypoxia inducible factor-1 during viral infections
por: Reyes, Antonia, et al.
Publicado: (2020)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
por: Domachowske, Joseph B., et al.
Publicado: (2021)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Gatt, Dvir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v31lto0i9ud800pabp61f7l33i